The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 331:1236 November 3, 1994 Number 18
NextNext

Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia with Aminocaproic Acid

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Saba, H. I.
-PubMed Citation
To the Editor: We read the Brief Report by Saba et al. (June 23 issue)1 on the treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid with a mixture of hope and concern. Although Saba and colleagues had success with aminocaproic acid, we know of three patients with hereditary hemorrhagic telangiectasia in whom aminocaproic acid failed to decrease bleeding.

Patient 1 was a 66-year-old man whose primary manifestation of hereditary hemorrhagic telangiectasia was chronic gastrointestinal bleeding from gastric and small-bowel telangiectasias. His bleeding persisted despite trials of estrogen and progesterone, danazol, testosterone, and oral norepinephrine in addition to multiple . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.